Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7408046 Treatment of bone-associated cancers

Patent 7408046 was granted and assigned to Poniard Pharmaceuticals, Inc. on August, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

Poniard Pharmaceuticals, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Paul G. Abrams0

Kent R. Thoelke0

Lauren Marie Tatalick0

Mark D. Hylarides0

Alan R. Fritzberg0

Elizabeth K. John0

James Kyle Bryan0

Date of Patent

August 5, 2008

0

Patent Application Number

108820540

Date Filed

June 30, 2004

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7408046 Treatment of bone-associated cancers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.